Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs SPDR Gold Trust (GLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs SPDR Gold Trust — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.06 (market cap $3.94B), while SPDR Gold Trust trades at $380.5 (market cap $141.50B). The key difference: SPDR Gold Trust is far larger — about 35.9× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and SPDR Gold Trust for 75 Days on average.
| EWTX | GLD | |
|---|---|---|
Market Cap | $3.94B | $141.50B |
Volume | 810,104 | 5,707,251 |
Sector | Health | — |
52-Week High | $48.35 | $495.90 |
52-Week Low | $14.89 | $362.32 |
Typical Hold Time | 0 Days | 75 Days |
Enterprise Value | $3.48B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GLD, tracking the price of gold, trades at $381.67, down 0.13% amid broader pressure from rising Treasury yields and a strong U.S. dollar. Technical indicators show a bearish bias with moving averages signaling sell pressure, while oscillators are neutral. Recent news highlights gold's struggle to maintain gains despite weak economic data, with support near $380. The absence of traditional stock fundamentals like P/E or revenue metrics reflects its nature as a commodity-backed ETF.
The outlook for GLD remains challenged by macroeconomic headwinds, including potential Federal Reserve rate hikes and elevated yields, which dampen gold's appeal. However, persistent inflation and geopolitical risks offer hedging opportunities. Risks include further dollar strength and yield increases, while any dovish Fed pivot could catalyze a rebound. Investors should weigh gold's role as a diversifier against ongoing monetary policy uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →
